Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
7.77
-0.22 (-2.75%)
Aug 10, 2026, 10:31 AM EDT - Market open
Aura Biosciences Employees
Aura Biosciences had 113 employees as of December 31, 2025. The number of employees increased by 4 or 3.67% compared to the previous year.
Employees
113
Change (1Y)
4
Growth (1Y)
3.67%
Revenue / Employee
n/a
Profits / Employee
-$994,628
Market Cap
857.03M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 113 | 4 | 3.67% | 113 | 0 |
| Dec 31, 2024 | 109 | 20 | 22.47% | 106 | 3 |
| Dec 31, 2023 | 89 | 17 | 23.61% | 88 | 1 |
| Dec 31, 2022 | 72 | 20 | 38.46% | 70 | 2 |
| Dec 31, 2021 | 52 | - | - | 52 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Kura Oncology | 260 |
| Geron | 258 |
| Omeros | 175 |
| Solid Biosciences | 121 |
| Annexon | 93 |
| Theravance Biopharma | 90 |
| Aclaris Therapeutics | 73 |
| SpyGlass Pharma | 68 |
AURA News
- 5 days ago - Aura Biosciences Transcript: EGM 2026 - Transcripts
- 4 weeks ago - Aura Biosciences Announces Appointment of Jeremy Bender, Ph.D., M.B.A., to Board of Directors - GlobeNewsWire
- 6 weeks ago - Aura Biosciences Proxy statement: Proxy filing - Filings
- 7 weeks ago - Aura Biosciences Proxy statement: Proxy filing - Filings
- 7 weeks ago - Auranova and Kenorland Announce Large Intrusion-Related Gold Discovery at the South Uchi Project, Ontario - Newsfile Corp
- 2 months ago - Aura Biosciences Transcript: AGM 2026 - Transcripts
- 2 months ago - Aura Biosciences completes enrollment in belzupacap sarotalocan trial - TheFly
- 2 months ago - Aura Biosciences Announces Enrollment Completion in Phase 3 CoMpass Trial of Bel-sar in Early Choroidal Melanoma - GlobeNewsWire